Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-1.04 %
$ 60.6 M
Market Cap
-167.0
P/E
ICCC - CASH FROM OPERATIONS
Cash from Operations ICCC - ImmuCell Corporation
358 K
LAST VALUE
49.39%
2 YEAR CAGR
8.92%
5 YEAR CAGR
1.70%
10 YEAR CAGR